About company

Shape Therapeutics’ next-generation gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. This is done by redirecting the human cellular machinery already present in our cells, thereby bypassing risks of in vivo immunogenicity and permanent off-target damages commonly associated with CRISPR-based technologies.

US
Unknown
Not verified company